Overview

Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia

Status:
Enrolling by invitation
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
STUDY OF INGREZZA (VALBENAZINE) FOR THE TREATMENT OF CERVICAL DYSTONIA
Phase:
Phase 4
Details
Lead Sponsor:
The Orthopedic Foundation